Roger Pomerantz Insider Trading $NTEC Intec Pharma Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Roger Pomerantz.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Roger Pomerantz. Roger Pomerantz is Director in Viracta Therapeutics, Inc. ($SNSS) and Chief Executive Officer in CONTRAFECT Corp ($CFRX) and Director in CONTRAFECT Corp ($CFRX) and Director in Seres Therapeutics, Inc. ($MCRB) and President and CEO in Seres Therapeutics, Inc. ($MCRB) and Director in Intec Pharma Ltd. ($NTEC) and Director in Rubius Therapeutics, Inc. ($RUBY).

Roger Pomerantz in Intec Pharma Ltd.

Trading Symbol: NTEC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Director
Holdings: 0 shares
Latest Transaction: Jul 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Roger Pomerantz in Intec Pharma Ltd.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CFRX, NTEC, RUBY, MCRB, SNSS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 17 2020NTECIntec Pharma Ltd.Pomerantz RogerDirectorOption ExerciseA0.3140,00012,30040,000
Jul 02 2019NTECIntec Pharma Ltd.Pomerantz RogerDirectorOption ExerciseA4.8620,00097,16020,000
Jul 02 2019NTECIntec Pharma Ltd.Pomerantz RogerDirectorOption ExerciseA4.8620,00097,16020,000

Page:   1